List of targets for current NeuroMab projects (95 total in 89 projects).
Fusions already performed listed in parentheses (letters indicate follow up fusions).
NeuroMab (55 targets in 52 projects)
AC8 (N208)
ASIC1a
Beclin-1 (N248A)
Brevican
Cav1.2
Clcn3 (N258)
Clcn4 (N222)
Clcn5 (N237)
Cornichon/CNIH (N200)
DECPG
DHAPG
Dopamine D2 receptor (N186A)
Dopamine D3 receptor
Egr3 (N216B)
FGF13B/FHF2B (N225A)
GABA(A)R, Alpha5
GFAP R79WT
GFAP R79C
GFAP R79H
GFAP R239WT
GFAP R239C
GFAP R239H
GFAP R416WT (N206A)
HCN1 external
INPP4a (N172B)
KCNQ3 (N223A)
LRRK2/Dardarin, C-terminus (N241A)
LRRK2/Dardarin, N3 (N231A)
MEAPG
Nav1.3 (N234)
Nav1.4 (N255)
Navbeta2 (N236A)
Neurexin-1 Alpha (N239A)
Neurexin-1 Alpha/Beta (N239A)
NrCAM
P2X7 receptor, extracellular
Pan-Connexin, extracellular
Pan-FGF/FHF-A (N235)
Pannexin-1, extracellular
Parkin-pTyr143 (N243A)
Parkin unmodified (N243A)
PDAP
SALM4
Slc4a3/AE3 (N242)
Slc4a4/NBC isoform A (N224)
Slc4a4/NBC isoform B (N224)
SynCAM4 (N244)
TARPGamma2/Stargazin (pan) (N245A)
TREK-1
TRIP8b (N212A)
TRPML1
TRPML2
TRPML3
TRPV1 (N221)
VGlut1 external (N249)
BrainDev (27 targets in 25 projects)
ARHGAP4
ATF5
CCRL2 (N184)
CLN3
CLN6
CLN8
CXCR2 (N146)
Gamma-protocadherin-C5 (N189B)
LRRTM2 (N209A)
LRRTM4
MeCP2-Arg162Me2a
MeCP2 unmodified
Notch1 (N253)
QKI-7b (N194)
SMN Delta7 (N179)
SMN Read-through (N179)
SMN Non-selective (N179)
SRGAP1
SRGAP2/FNBP2
Synaptotagmin 5C2A
Synaptotagmin 6C2A
Synaptotagmin 7C2A
Synaptotagmin 10C2A
Synaptotagmin 12C2A
Synaptotagmin 3C2B
Synaptotagmin 9C2B
WRP
Epigenetics (3 targets in 2 projects)
Histone H2A-Lys37Me1 (N137, N137A)
Histone H2A unmodified (N137, N137A)
Histone H1.2
Rare Disease (10 targets in 10 projects)
Boymaw (N240)
CDH23
DNAH1 (N251)
DNAH7 (N250)
EF2-pSer595
Pex6 (N233)
Pex7 (N232)
PTS1
RSPH4/RSHL3 (N254)
WRN